1. Sweden Stocks

  2. •

    Industrials

  3. •

    Specialty Business Services
iZafe Group AB

iZafe Group AB

IZAFE-B.ST
iZafe Group ABSE flagStockholm Stock Exchange
0.35
SEK
-0.03
- -
142.91MMarket Cap
iZafe Group AB
IZAFE-B.ST
(Stockholm Stock Exchange)

Recent

price

0.35

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
- -
- -
- -
- -
- -
- -
- -
0.01
0.35
0.41
0.19
0.01
0.01
0.01
0.03
0.02
0.02
Revenue per Share
-1.06
-0.74
-0.36
-0.88
-0.38
-0.28
-0.55
-0.35
-0.53
-0.66
-0.28
-0.78
-0.29
-0.14
-0.08
-0.05
-0.05
Basic EPS, GAAP
- -
- -
-0.42
-0.12
-0.11
-0.19
-0.47
-0.8
-1.12
-0.56
-0.57
-0.73
-0.3
-0.05
-0.05
-0.05
-0.03
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-1.35
-0.04
0.47
0.2
0.02
0.75
-0.29
-0.38
-0.62
-0.63
-0.67
-0.63
-1.16
-0.46
-0.46
-0.37
-0.37
Book Value per Share
-0.1
-0.04
-0.61
-0.64
-0.67
-0.37
0.13
0.14
-1.21
-0.35
0.12
0.45
- -
0.03
-0.03
-0.04
- -
Tangible Book Value per Share
6
7
8
8
8
9
12
12
21
35
46
46
80
232
266
337
357
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
8
14
9
- -
1
2
8
6
7
Sales/Revenue/Turnover
-157,298.05
-18,620.98
-7,638.94
-150,337.75
- -
- -
- -
-2,734.19
-141.88
-153.73
-293.21
-7,528.05
-3,210.43
-2,040.83
-262.42
-306.74
-269.84
Operating Margin (%)
2
2
1
7
2
2
1
- -
1
6
5
5
4
23
4
5
5
Depreciation Expense
-6
-5
-3
-7
-3
-3
-6
-4
-11
-23
-13
-36
-24
-32
-21
-17
-19
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-157,526.53
-18,704.64
-7,462.56
-126,867.08
- -
- -
- -
-2,754.19
-149.41
-161.33
-143.24
-8,207.01
-3,227.16
-1,765.92
-257.85
-278.35
-273.15
Profit Margin (%)
- -
- -
- -
-1
-1
-1
2
2
-21
-10
5
19
4
6
-8
-2
- -
Working Capital
1
- -
- -
1
2
1
1
- -
1
4
- -
4
3
1
- -
- -
- -
LT Debt
4
3
19
12
9
9
5
11
10
37
29
41
39
25
10
12
24
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
-268.88
-351.51
-71.64
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
365
370
407
Market Capitalization
142
162
134

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
10
6
13
Cash, Cash Equivalents & STI
5
2
7
Accounts Receivable, Net
1
1
2
Inventories
3
2
2
Total Current Liabilities
8
9
14
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
26.1%
-8.5%
20.12%
Free Cash Flow
41.75%
-5.42%
19.63%
Net Income, GAAP
46.75%
26.22%
-18.69%
Sales/Revenue/Turnover
- -
86.34%
-24.68%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
3
- -
2
2
8
2025
1
1
1
2
6
2026
2
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.02
-0.02
-0.02
-0.02
-0.08
2025
-0.01
-0.01
-0.01
-0.01
-0.05
2026
-0.02
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Magnus Concordia Group Limited (1172.HK)
Kaili Catalyst & New Materials Co.,Ltd. (688269.SS)
Yasuda Logistics Corporation (9324.T)
Servizi Italia S.p.A. (SRI.MI)
China Green Broad Ecological Technology Company Limited (1253.HK)
Global Service Center Public Company Limited (GSC.BK)
Business
iZafe Group AB iZafe Group AB (publ) (IZAFE-B.ST), a Swedish Life Science company headquartered in Stockholm and founded in 2008, develops, researches and markets digital medical solutions and services for safer medication management at home; its core products include the Dosell automated medication dispenser robot, which handles pre-packed medication pouches, enables independent dosing, sends reminders and alerts for scheduled doses and reduces risks of errors such as overdosing or missed intake; the Pilloxa SaaS platform with smart pillbox, offering real-time patient insights, data quality improvements for clinical trials, medication reminders, statistics and personalized care integration; and connected dosing bags supporting overall compliance and health monitoring. The company targets private individuals, pharmaceutical firms, public and private healthcare providers across Sweden, the Nordics and globally, primarily through established distribution partners, with operations listed on Nasdaq First North Growth Market since 2018. Recent developments encompass the acquisition of its Dutch distributor Thuisapparatuur Nederland B.V. in September 2025 to accelerate annual recurring revenue targets in Europe's largest medication dispenser market; strategic partnerships including with Vakt og Alarm for Norway's initial major Dosell deal in November 2025, Skand ehf for Iceland market entry in November 2025, AddSecure Smart Care Oy for Finland in July 2025 and a letter of intent with JDM Innovation GmbH of the PHOENIX group in May 2025 for broader European collaboration; surpassing 1,000 active Dosell units in operation by June 2025; and a directed share issue of SEK 10 million in June 2025 alongside board member share acquisitions signaling strengthened ownership commitment.